SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,972,894 | -30.9% | 354,502 | -34.7% | 0.08% | -23.2% |
| Q2 2023 | $62,174,355 | -16.2% | 542,912 | +0.8% | 0.10% | -19.5% |
| Q1 2023 | $74,212,866 | +51.8% | 538,437 | +42.7% | 0.12% | +48.2% |
| Q4 2022 | $48,884,441 | +67.1% | 377,253 | +42.5% | 0.08% | +59.6% |
| Q3 2022 | $29,255,000 | +86.4% | 264,674 | +26.4% | 0.05% | +100.0% |
| Q2 2022 | $15,693,000 | – | 209,368 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |